The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Poynard, T., Marcellin, P., Lee, S. S., Niederau, C., Minuk, G. S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07124-4 · Cited by 2,318
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Self-citationRNA virus error catastrophe: Direct molecular test by using ribavirin
Crotty, S., Cameron, C. E., & Andino, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111085598 · Cited by 849
Reichard, O., Norkrans, G., Frydén, A., Braconier, J.-H., Sönnerborg, A., & Weiland, O. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06088-1 · Cited by 629
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial
Bodenheimer, H. C., Lindsay, K. L., Davis, G. L., Lewis, J. H., Thung, S. N., & Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260231 · Cited by 380
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
Dusheiko, G. M., Main, J., Thomas, H. C., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80225-x · Cited by 355
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
Lau, J. Y. N., Tam, R. C., Liang, J. T., & Hong, Z. (2002) · Hepatology · doi:10.1053/jhep.2002.32672 · Cited by 337
Cited by
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
Feld, J. J., & Hoofnagle, J. H. (2005) · Nature · doi:10.1038/nature04082 · Cited by 992
Kinetics of Influenza A Virus Infection in Humans
Baccam, P., Beauchemin, C., Macken, C. A., Hayden, F. G., & Perelson, A. S. (2006) · Journal of Virology · doi:10.1128/jvi.01623-05 · Cited by 756
Self-citationMechanisms of action of ribavirin against distinct viruses
Graci, J. D., & Cameron, C. E. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.483 · Cited by 549
American Gastroenterological Association Technical Review on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.010 · Cited by 384
Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
Rong, L., Dahari, H., Ribeiro, R. M., & Perelson, A. S. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000544 · Cited by 355
Self-citation
Metadata
- Authors
- Dixit, N. M., Layden-Almer, J. E., Layden, T. J., & Perelson, A. S.
- Venue
- Nature
- Published
- 2004-12
- Volume
- 432
- Issue
- 7019
- Pages
- 922-924
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1967080996
- Cited by
- 369
- References
- 19
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. https://app.cochat.ai/papers/10.1038/nature03153
- The paper
- Dixit, N. M., Layden-Almer, J. E., Layden, T. J., & Perelson, A. S. (2004). Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature. https://doi.org/10.1038/nature03153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.